ZhuZhou QianJin Pharmaceutical Co Ltd Cash Flow Reinvestment Rate
ZhuZhou QianJin Pharmaceutical Co Ltd cash flow reinvestment rate. ZhuZhou QianJin Pharmaceutical Co Ltd (600479) has a Cash Flow Reinvestment Rate of 0.08x as of September 2025, reinvesting CN¥23.89 Million (capex CN¥23.89 Million ) from operating cash flow of CN¥288.83 Million. Explore 600479 operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of ZhuZhou QianJin Pharmaceutical Co Ltd (2002–2025)
Cash flow reinvestment rate of ZhuZhou QianJin Pharmaceutical Co Ltd from 2002 to 2025. Historical reinvestment intensity for ZhuZhou QianJin Pharmaceutical Co Ltd across 24 annual periods. Explore ZhuZhou QianJin Pharmaceutical Co Ltd capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
ZhuZhou QianJin Pharmaceutical Co Ltd Cash Flow Reinvestment Rate by Year (2002–2025)
ZhuZhou QianJin Pharmaceutical Co Ltd cash flow reinvestment rate by year from 2002 to 2025. Year-by-year capital reinvestment analysis for ZhuZhou QianJin Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see 600479 cash flow metrics.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.94x | CN¥933.22 Million | CN¥480.24 Million | CN¥124.17 Million | ▲ +4.5% |
| 2024 | 1.86x | CN¥741.57 Million | CN¥398.77 Million | CN¥47.32 Million | ▲ +18.7% |
| 2023 | 1.57x | CN¥694.07 Million | CN¥443.12 Million | CN¥43.99 Million | ▲ +633.7% |
| 2022 | 0.21x | CN¥156.58 Million | CN¥733.47 Million | CN¥34.43 Million | ▲ +6.8% |
| 2021 | 0.20x | CN¥97.06 Million | CN¥485.57 Million | CN¥71.88 Million | ▼ -89.1% |
| 2020 | 1.83x | CN¥990.84 Million | CN¥542.37 Million | CN¥97.24 Million | ▲ +33.0% |
| 2019 | 1.37x | CN¥213.57 Million | CN¥155.49 Million | CN¥40.61 Million | ▲ +44.2% |
| 2018 | 0.95x | CN¥365.30 Million | CN¥383.47 Million | CN¥46.39 Million | ▼ -40.9% |
| 2017 | 1.61x | CN¥457.16 Million | CN¥283.47 Million | CN¥57.30 Million | ▲ +12.4% |
| 2016 | 1.43x | CN¥202.06 Million | CN¥140.88 Million | CN¥81.50 Million | ▼ -61.2% |
| 2015 | 3.69x | CN¥249.32 Million | CN¥67.48 Million | CN¥84.47 Million | ▲ +926.7% |
| 2014 | 0.36x | CN¥65.97 Million | CN¥183.34 Million | CN¥65.97 Million | ▼ -41.2% |
| 2013 | 0.61x | CN¥84.26 Million | CN¥137.63 Million | CN¥84.26 Million | ▼ -52.7% |
| 2012 | 1.30x | CN¥256.26 Million | CN¥197.82 Million | CN¥256.26 Million | ▼ -54.2% |
| 2011 | 2.83x | CN¥63.87 Million | CN¥22.58 Million | CN¥63.87 Million | ▲ +89.4% |
| 2010 | 1.49x | CN¥58.44 Million | CN¥39.13 Million | CN¥58.44 Million | ▼ -10.9% |
| 2009 | 1.68x | CN¥123.31 Million | CN¥73.54 Million | CN¥123.31 Million | ▼ -34.5% |
| 2008 | 2.56x | CN¥95.30 Million | CN¥37.20 Million | CN¥95.30 Million | ▲ +801.0% |
| 2007 | 0.28x | CN¥22.53 Million | CN¥79.26 Million | CN¥22.53 Million | ▲ +59.7% |
| 2006 | 0.18x | CN¥21.39 Million | CN¥120.12 Million | CN¥21.39 Million | ▼ -18.6% |
| 2005 | 0.22x | CN¥16.74 Million | CN¥76.50 Million | CN¥16.74 Million | ▼ -92.9% |
| 2004 | 3.06x | CN¥56.50 Million | CN¥18.45 Million | CN¥56.50 Million | ▲ +358.2% |
| 2003 | 0.67x | CN¥34.05 Million | CN¥50.96 Million | CN¥34.05 Million | ▼ -93.1% |
| 2002 | 9.75x | CN¥59.24 Million | CN¥6.07 Million | CN¥59.24 Million | — |